SCHEMBL25837333

SCHEMBL25837333

COOC(=O)c1c(O)cc(O)cc1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 3/20 0.45
▸ EGFR P00533 1/20 0.44
▸ ALOX5 P09917 1/20 0.43
▸ NR1H2 P55055 1/20 0.42
▸ NR1H3 Q13133 1/20 0.42
▸ CYP3A4 P08684 3/20 0.41
▸ ACHE P22303 1/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ MAPT P10636 3/20 0.41
▸ KCNA3 P22001 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ LMNA P02545 2/20 0.39
▸ ESR1 P03372 2/20 0.39
▸ ESR2 Q92731 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGD P15428 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22699377 0.84 NR1H2 (0.66) NR1H2NR1H3CYP3A4MEN1KMT2A
SCHEMBL22068538 0.79 ALOX5 (0.53) BACE1EGFRALOX5CYP3A4ACHE
SCHEMBL11323927 0.72 EGFR (0.54) BACE1EGFRCYP3A4ACHEMEN1
SCHEMBL8707576 0.72 ESR1 (0.37) BACE1EGFRALOX5NR1H2NR1H3
SCHEMBL8575646 0.70 SLC6A3 (0.56) MEN1KMT2ASMN1; SMN2LMNAHTT
SCHEMBL13898639 0.70 EGFR (0.45) EGFRMEN1KMT2AMAPTTDP1
SCHEMBL26725174 0.68 HSD17B10 (0.52) EGFRALOX5NR1H2NR1H3CYP3A4
SCHEMBL9049651 0.68 CA12 (0.69) EGFRMEN1KMT2AMAPTTDP1
SCHEMBL3686460 0.68 BACE1 (0.62) BACE1ALOX5CYP3A4MEN1KMT2A
SCHEMBL17445903 0.68 ALOX5 (0.57) BACE1ALOX5CYP3A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11693313-B2 Resist composition and method of forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2023-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11693313-B2 Resist composition and method of forming resist pattern C1R, C1S, C9 BACE1 1738/4885EGFR 2218/4885ALOX5 2698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback